We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

194 hedge funds and large institutions have $149M invested in Editas Medicine in 2025 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 57 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

492% more call options, than puts

Call options by funds: $4.92M | Put options by funds: $830K

64% more capital invested

Capital invested by funds: $90.9M → $149M (+$58.4M)

4% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 23

0% more funds holding

Funds holding: 194 → 194 (0)

1.47% less ownership

Funds ownership: 49.34% → 47.87% (-1.5%)

18% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 57

Holders
194
Holders Change
–
Holders Change %
0%
% of All Funds
2.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
47
Reduced
57
Closed
23
Calls
$4.92M
Puts
$830K
Net Calls
+$4.09M
Net Calls Change
+$2.85M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.35M
2
N
Nuveen
North Carolina
+$3.19M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$1.97M
4
Two Sigma Investments
Two Sigma Investments
New York
+$1.71M
5
Walleye Capital
Walleye Capital
New York
+$1.1M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$4.3M
2
WP
Woodline Partners
California
-$1.86M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$1.32M
4
Morgan Stanley
Morgan Stanley
New York
-$929K
5
Citadel Advisors
Citadel Advisors
Florida
-$772K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
176
Parallel Advisors
California
$208 – – –
DIP
177
DT Investment Partners
Pennsylvania
$188 – – –
IA
178
IFP Advisors
Florida
$187 -$13.9K -4,982 -99%
Comerica Bank
179
Comerica Bank
Texas
$187 -$112 -40 -43%
GWP
180
Gen-Wealth Partners
Michigan
$184 – – –
CFFP
181
Center for Financial Planning
Michigan
$174 – – –
NRG
182
Nemes Rush Group
Michigan
$174 – – –
NSIM
183
North Star Investment Management
Illinois
$132 – – –
CTA
184
Colonial Trust Advisors
South Carolina
$104 – – –
AF
185
Advisornet Financial
Minnesota
$87 -$70 -25 -50%
CA
186
Clearstead Advisors
Ohio
$87 – – –
MCM
187
MAI Capital Management
Ohio
$77 – – –
HI
188
Harbour Investments
Wisconsin
$66 – – –
RWML
189
RAFFA WEALTH MANAGEMENT, LLC
District of Columbia
$66 – – –
CA
190
CoreCap Advisors
Michigan
$52 -$279 -100 -87%
AFWM
191
Abich Financial Wealth Management
Virginia
$42 +$33 +12 New
FP
192
Financial Perspectives
Minnesota
$21 – – –
MA
193
MCF Advisors
Kentucky
$4 – – –
WP
194
Woodline Partners
California
– -$1.86M -846,399 Closed
Marshall Wace
195
Marshall Wace
United Kingdom
– -$312K -142,008 Closed
VF
196
Virtu Financial
New York
– -$279K -126,972 Closed
GCP
197
GSA Capital Partners
United Kingdom
– -$181K -82,343 Closed
Group One Trading
198
Group One Trading
Illinois
– -$225K -80,702 Closed
SOW
199
State of Wyoming
Wyoming
– -$146K -66,427 Closed
AC
200
AXQ Capital
New Jersey
– -$104K -47,083 Closed
5 6 7
8
9

EDIT Hedge Fund Activity: Q3 2025 in Review

194 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2025, worth a combined $149M — up 64% from $90.9M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new EDIT positions and 23 closed out — a net gain of 1 holder — while 47 added to existing stakes and 57 trimmed.

The largest buyer was BlackRock, adding an estimated $3.35M. The largest seller was Millennium Management, cutting an estimated $4.3M.

  • 194 institutional investors held Editas Medicine (EDIT) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $149M of Editas Medicine stock for Q3 2025, up 64% quarter-over-quarter.
  • 24 funds opened new Editas Medicine positions in Q3 2025 and 23 closed out, a net change of +1 holder.
  • The largest Editas Medicine buyer in Q3 2025 was BlackRock, an estimated $3.35M added.
  • The largest Editas Medicine seller in Q3 2025 was Millennium Management, an estimated $4.3M sold.

Based on aggregated 13F filings for Q3 2025.